(Q38801384)

6 September 2017

title

Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Alexander N Orekhov

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Yuri V Bobryshev

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

1 reference

4 April 2016

1 reference

Journal of Molecular and Cellular Cardiology

6 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

107-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

The inflammatory response in myocardial infarction

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Functional mechanisms of myocardial microcirculation in left ventricular hypertrophy: a hypothetical model of capillary remodeling post myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Most mammalian mRNAs are conserved targets of microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Role of microRNAs in cardiac remodeling and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNAs and Cardiac Cell Fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 in Cardiac Diseases and Cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Developmental expression and evolution of muscle-specific microRNAs conserved in vertebrates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Characterization of the compact bicistronic microRNA precursor, miR-1/miR-133, expressed specifically in Ciona muscle tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Roles of the canonical myomiRs miR-1, -133 and -206 in cell development and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA regulatory networks in cardiovascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Myostatin genotype regulates muscle-specific miRNA expression in mouse pectoralis muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Distinct amino acid-sensing mTOR pathways regulate skeletal myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Follistatin-mediated skeletal muscle hypertrophy is regulated by Smad3 and mTOR independently of myostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The RNA-binding protein TDP-43 selectively disrupts microRNA-1/206 incorporation into the RNA-induced silencing complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Myotonic dystrophy: diagnosis, management and new therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNAs get to the heart of development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNA-1 regulates sarcomere formation and suppresses smooth muscle gene expression in the mammalian heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Protein phosphatase 2A affects myofilament contractility in non-failing but not in failing human myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA regulation of cell lineages in mouse and human embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Myocyte enhancer factor 2C and Nkx2-5 up-regulate each other's expression and initiate cardiomyogenesis in P19 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Expression of microRNAs and their target mRNAs in human stem cell-derived cardiomyocyte clusters and in heart tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A genome-wide screen reveals a role for microRNA-1 in modulating cardiac cell polarity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Overexpression of microRNA-1 promotes cardiomyocyte commitment from human cardiovascular progenitors via suppressing WNT and FGF signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Induction of microRNA-1 by myocardin in smooth muscle cells inhibits cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 Regulates Smooth Muscle Cell Differentiation by Repressing Kruppel-Like Factor 4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-1/133a clusters cooperatively specify the cardiomyogenic lineage by adjustment of myocardin levels during embryonic heart development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA induced cardiac reprogramming in vivo: evidence for mature cardiac myocytes and improved cardiac function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Reprogramming of human fibroblasts toward a cardiac fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

7 January 2021

Cardiac channelopathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA regulation of cardiac conduction and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

L-type Ca2+ channels of the embryonic mouse heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

[Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The homeodomain transcription factor Irx5 establishes the mouse cardiac ventricular repolarization gradient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Effect of Arsenic Trioxide on QT Interval in Patients With Advanced Malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Calcium channels — basic aspects of their structure, function and gene encoding; anesthetic action on the channels — a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac sodium transport and excitation-contraction coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Sodium/calcium exchanger: influence of metabolic regulation on ion carrier interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Calcium cycling in heart failure: the arrhythmia connection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Gap junctions - guards of excitability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Remodeling of gap junctional channel function in epicardial border zone of healing canine infarcts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA- 1 represses Cx43 expression in viral myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Posttranscriptional regulation of connexin-43 expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A translational study of circulating cell-free microRNA-1 in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

IGF-1 prevents oxidative stress induced-apoptosis in induced pluripotent stem cells which is mediated by microRNA-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Direct evidence for calcium conductance of hyperpolarization-activated cyclic nucleotide-gated channels and human native If at physiological calcium concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Single-channel properties support a potential contribution of hyperpolarization-activated cyclic nucleotide-gated channels and If to cardiac arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Feedback mechanisms for cardiac-specific microRNAs and cAMP signaling in electrical remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 aggravates cardiac oxidative stress by post-transcriptional modification of the antioxidant network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Insulin ameliorates miR-1-induced injury in H9c2 cells under oxidative stress via Akt activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Remote ischemic conditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Regulation of microRNAs by Brahma-related gene 1 (Brg1) in smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Myogenic microRNA expression requires ATP-dependent chromatin remodeling enzyme function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNAs in cardiac development and regeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The miR-206/133b cluster is dispensable for development, survival and regeneration of skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac ryanodine receptor phosphorylation by CaM Kinase II: keeping the balance right

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Down-regulation of miR-1/miR-133 contributes to re-expression of pacemaker channel genes HCN2 and HCN4 in hypertrophic heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Restoring depressed HERG K+ channel function as a mechanism for insulin treatment of abnormal QT prolongation and associated arrhythmias in diabetic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The role of microRNA-133 in cardiac hypertrophy uncovered

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac microRNA-133 is down-regulated in thyroid hormone-mediated cardiac hypertrophy partially via Type 1 Angiotensin II receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Repolarization reserve: a moving target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA microarray expression profiling in human myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Role of miR-1 and miR-133a in myocardial ischemic postconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

AKT signalling in the failing heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Evolution of sarcomeric myosin heavy chain genes: evidence from fish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNAs in cardiomyocyte development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Signaling chromatin to make muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MEF2: a central regulator of diverse developmental programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

The emerging role of miR-208a in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Control of stress-dependent cardiac growth and gene expression by a microRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A long noncoding RNA protects the heart from pathological hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

microRNAs put their signatures on the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac hypertrophy and thyroid hormone signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MiRNA-208a and miRNA-208b are triggered in thyroid hormone-induced cardiac hypertrophy - role of type 1 Angiotensin II receptor (AT1R) on miRNA-208a/α-MHC modulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Cardiac troponins and renal function in nondialysis patients with chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-208a as a biomarker of isoproterenol-induced cardiac injury in Sod2+/- and C57BL/6J wild-type mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Plasma miR-208 as a biomarker of myocardial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Plasma microRNA 499 as a biomarker of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Transcoronary concentration gradients of circulating microRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Release kinetics of circulating muscle-enriched microRNAs in patients undergoing transcoronary ablation of septal hypertrophy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Toward microRNA-based therapeutics for heart disease: the sense in antisense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Prdm1a and miR-499 act sequentially to restrict Sox6 activity to the fast-twitch muscle lineage in the zebrafish embryo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Control of muscle fibre-type diversity during embryonic development: the zebrafish paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Developmental expression and cardiac transcriptional regulation of Myh7b, a third myosin heavy chain in the vertebrate heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Evolution of the myosin heavy chain gene MYH14 and its intronic microRNA miR-499: muscle-specific miR-499 expression persists in the absence of the ancestral host gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

A human 3' miR-499 mutation alters cardiac mRNA targeting and function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Elevated miR-499 levels blunt the cardiac stress response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Use of circulating microRNAs to diagnose acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Decrease of mitochondrial p53 during late apoptosis is linked to its dephosphorylation on serine 20

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome c during apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

SOX6 suppresses cyclin D1 promoter activity by interacting with beta-catenin and histone deacetylase 1, and its down-regulation induces pancreatic beta-cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

Human cardiac stem cell differentiation is regulated by a mircrine mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.03.015

10.1016/J.YJMCC.2016.03.015

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27056419%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference